CONJUGATES FOR PREVENTION OR TREATMENT OF NICOTINE ADDICTION
PROBLEM TO BE SOLVED: To provide nicotine-derived haptens, nicotine-derived hapten-carrier conjugates, and vaccine compositions containing the conjugates, which are useful for enhancing smoking quit rates or reducing smoking relapse rates in smoking cessation therapy and for prevention or treatment...
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
20.08.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PROBLEM TO BE SOLVED: To provide nicotine-derived haptens, nicotine-derived hapten-carrier conjugates, and vaccine compositions containing the conjugates, which are useful for enhancing smoking quit rates or reducing smoking relapse rates in smoking cessation therapy and for prevention or treatment of nicotine addiction.SOLUTION: The present invention relates to nicotine-derived hapten-carrier conjugates represented by the formula (III). [W is -CH- or -O-; -(spacer)- is a C-Calkylene group, a C-Calkylene group interrupted by 1 to 4 oxygen atoms and optionally interrupted by a -N(H)C(O)-, or the like; Xis -NH- or the like; m is 0 or 1; n is an integer from 1 to 1000; and Y is a carrier protein such as bacterial toxoids.]
【課題】禁煙治療における断煙率の向上、喫煙再発率の低減、及びニコチン中毒の予防又は治療に有用なニコチン誘導ハプテン、ニコチン誘導ハプテン−担体コンジュゲート、及び前記コンジュゲートを含有するワクチン組成物の提供。【解決手段】式(III)で表されるニコチン誘導ハプテン−担体コンジュゲート。[Wは−CH2−又は−O−;−(スペーサー)−はC1〜C8アルキレン基、或いは1〜4個の酸素原子によって中断されており、−N(H)C(O)−によって中断されていてもよいC1〜C12アルキレン基等;X*は−NH−等;mは0又は1;nは1〜1000の整数;Yは細菌トキソイド等の担体タンパク質]【選択図】なし |
---|---|
AbstractList | PROBLEM TO BE SOLVED: To provide nicotine-derived haptens, nicotine-derived hapten-carrier conjugates, and vaccine compositions containing the conjugates, which are useful for enhancing smoking quit rates or reducing smoking relapse rates in smoking cessation therapy and for prevention or treatment of nicotine addiction.SOLUTION: The present invention relates to nicotine-derived hapten-carrier conjugates represented by the formula (III). [W is -CH- or -O-; -(spacer)- is a C-Calkylene group, a C-Calkylene group interrupted by 1 to 4 oxygen atoms and optionally interrupted by a -N(H)C(O)-, or the like; Xis -NH- or the like; m is 0 or 1; n is an integer from 1 to 1000; and Y is a carrier protein such as bacterial toxoids.]
【課題】禁煙治療における断煙率の向上、喫煙再発率の低減、及びニコチン中毒の予防又は治療に有用なニコチン誘導ハプテン、ニコチン誘導ハプテン−担体コンジュゲート、及び前記コンジュゲートを含有するワクチン組成物の提供。【解決手段】式(III)で表されるニコチン誘導ハプテン−担体コンジュゲート。[Wは−CH2−又は−O−;−(スペーサー)−はC1〜C8アルキレン基、或いは1〜4個の酸素原子によって中断されており、−N(H)C(O)−によって中断されていてもよいC1〜C12アルキレン基等;X*は−NH−等;mは0又は1;nは1〜1000の整数;Yは細菌トキソイド等の担体タンパク質]【選択図】なし |
Author | KESHAB BHATTACHARYA PAUL ROBERT MEHELIC BROWN ALAN DANIEL LIN HOWARD JONES JARI ILMARI FINNEMAN DAVIS HEATHER LYNN PARAG ASHOK KOLHE DAVID ROBERT STEAD NICKOLAS ANASTASIOU ERIN KRISTEN PARSONS DAVID P GERVAIS JAMES RICHARD MERSON JENNIFER MARIE THORN MICHAEL JOHN MCCLUSKIE DAVID CAMERON PRIDE |
Author_xml | – fullname: JARI ILMARI FINNEMAN – fullname: PARAG ASHOK KOLHE – fullname: DAVID CAMERON PRIDE – fullname: MICHAEL JOHN MCCLUSKIE – fullname: JAMES RICHARD MERSON – fullname: DAVIS HEATHER LYNN – fullname: DAVID ROBERT STEAD – fullname: ERIN KRISTEN PARSONS – fullname: BROWN ALAN DANIEL – fullname: JENNIFER MARIE THORN – fullname: NICKOLAS ANASTASIOU – fullname: DAVID P GERVAIS – fullname: LIN HOWARD JONES – fullname: PAUL ROBERT MEHELIC – fullname: KESHAB BHATTACHARYA |
BookMark | eNrjYmDJy89L5WSwcfb38wp1dwxxDVZw8w9SCAhyDXP1C_H091MA8kKCXB1DfIF8BX83BT9PZ_8QTz9XBUcXF09nkBIeBta0xJziVF4ozc2g5OYa4uyhm1qQH59aXJCYnJqXWhLvFWBkYGhqaGJubmHqaEyUIgCAcCv7 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | ニコチン中毒の予防または治療用コンジュゲート |
ExternalDocumentID | JP2015147785A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2015147785A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:56:06 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Japanese |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2015147785A3 |
Notes | Application Number: JP20150068524 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150820&DB=EPODOC&CC=JP&NR=2015147785A |
ParticipantIDs | epo_espacenet_JP2015147785A |
PublicationCentury | 2000 |
PublicationDate | 20150820 |
PublicationDateYYYYMMDD | 2015-08-20 |
PublicationDate_xml | – month: 08 year: 2015 text: 20150820 day: 20 |
PublicationDecade | 2010 |
PublicationYear | 2015 |
RelatedCompanies | PFIZER VACCINES LLC |
RelatedCompanies_xml | – name: PFIZER VACCINES LLC |
Score | 3.1127365 |
Snippet | PROBLEM TO BE SOLVED: To provide nicotine-derived haptens, nicotine-derived hapten-carrier conjugates, and vaccine compositions containing the conjugates,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CONJUGATES FOR PREVENTION OR TREATMENT OF NICOTINE ADDICTION |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150820&DB=EPODOC&locale=&CC=JP&NR=2015147785A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNpzKdShDpW7Hb0nYFh3Rt6lpYW2Y39jbSHwMVtuEq_vteQqd72lsugXA5uCTf5e4LwONCNzJqpVRFjNxFgJJTlXMtV3OeGmm7yHNd_nU4Co3hhAYzfVaDz20tjOQJ_ZHkiOhRGfp7Kffr9X8Qy5W5lZun9B27Vi9e0neVCh0LcvOOpriDPosjN3IUx-kHsRKO5VibmmZPtw_gUNyjBdE-mw5EWcp690zxzuAoxumW5TnUPngDTpzt12sNOB5VL97YrJxvcwHPThQGk1c7YW8EsRtB401ZKEJMBKVkzOxEMPOTyCOhj1DdDxmxXdeXaSKX8OCxxBmqqMb8b9HzIN5RuXsF9eVqWTSBZIZpFZrR002rRwuuI1zKqMkXmWUtuqbGr6G1Z6KbvaMtOBWSCJl2tFuol1_fxR2euWV6L231CyL6f5E |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq6LWRxDJLZi2m2wDFknzsIntJtS09BY2j4IKbbER_76TpdWeetvdgWF2YHb4ZucB8DDT9JQYCVEQI7cRoGRE4VzNlIwnetLMs0wTsw6HTO-PiT_VphX43NTCiD6hP6I5IlpUivZeiPd6-R_EskVu5eoxecejxbMbdW15jY7L5uYtVbZ7XScM7MCSLavrhzIbCVqTUNrRzD3Yp4gJBVaa9MqylOW2T3GP4SBEdvPiBCofvA41azN6rQ6Hw_WPNy7Xxrc6hScrYP74xYycNwmxm4TKmzisDDFJuItGjhmVnfmlwJWYh1DdY45k2rYn0kTO4N51IquvoBjx36VjP9wSuX0O1flinl-AlOrUyFW9o1GjQ3KuIVxKCeWz1DBmbaryS2jsYHS1k3oHtX40HMQDj7024KiklOHTlnoN1eLrO79B_1skt0Jvvz7kgns |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CONJUGATES+FOR+PREVENTION+OR+TREATMENT+OF+NICOTINE+ADDICTION&rft.inventor=JARI+ILMARI+FINNEMAN&rft.inventor=PARAG+ASHOK+KOLHE&rft.inventor=DAVID+CAMERON+PRIDE&rft.inventor=MICHAEL+JOHN+MCCLUSKIE&rft.inventor=JAMES+RICHARD+MERSON&rft.inventor=DAVIS+HEATHER+LYNN&rft.inventor=DAVID+ROBERT+STEAD&rft.inventor=ERIN+KRISTEN+PARSONS&rft.inventor=BROWN+ALAN+DANIEL&rft.inventor=JENNIFER+MARIE+THORN&rft.inventor=NICKOLAS+ANASTASIOU&rft.inventor=DAVID+P+GERVAIS&rft.inventor=LIN+HOWARD+JONES&rft.inventor=PAUL+ROBERT+MEHELIC&rft.inventor=KESHAB+BHATTACHARYA&rft.date=2015-08-20&rft.externalDBID=A&rft.externalDocID=JP2015147785A |